Endovascular management of venous malformations

Phlebology

Volumn 22, Issue 6, 2007, Pages 264-275

  Rosenblatt, M ^a  

^a Connecticut Image Guided Surgery ^*  (United States)

Author keywords

Embolization; Endovascular therapy; Sclerosants; Varicose veins; Venous malformations

Indexed keywords

ALCOHOL; ETHIBLOC; IODINATED CONTRAST MEDIUM; METRIZAMIDE; MONOETHANOLAMINE OLEATE; POLIDOCANOL; SCLEROSING AGENT; TETRADECYL SULFATE SODIUM;

ANGIOOSTEOHYPERTROPHY SYNDROME; ARTIFICIAL EMBOLISM; CELLULITIS; CENTRAL NERVOUS SYSTEM DEPRESSION; CLINICAL FEATURE; COMPARTMENT SYNDROME; DEEP VEIN THROMBOSIS; DIAGNOSTIC IMAGING; DRUG MECHANISM; HEART ARREST; HEART ARRHYTHMIA; HEMOLYSIS; HUMAN; HYPERPIGMENTATION; HYPERTENSION; HYPERTHERMIA; HYPOGLYCEMIA; LUNG EMBOLISM; NERVE INJURY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PHLEBOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SHOCK; SIDE EFFECT; SKIN INJURY; SKIN NECROSIS; SWELLING; ULCER; ULTRASOUND; VARICOSIS; VEIN MALFORMATION;

HUMANS; MICROCIRCULATION; TEMPERATURE; TREATMENT OUTCOME; VASCULAR MALFORMATIONS; VEINS;

EID: 42149132147     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1258/026835507782655290     Document Type: Review

References (71)

1. Upton J, Mulliken JB, Murray JE. Classification and rationale for management of vascular anomalies in the upper extremity. J Hand Surg Am 1985;10:970-5
2. Mulliken JB. Cutaneous vascular anomalies. Semin Vasc Surg 1993;6:204-18
3. Belov S. Anatomopathological classification of congenital vascular defects. Semin Vasc Surg 1993;6:219-24
4. Chang MW. Updated classification of haemangiomas and other vascular anomalies. Lymphat Res Biol 2003;1:259-65
5. Puig S, Aref H, Chigot V, Bonin B, Brunelle F. Classification of venous malformations in children and implications for sclerotherapy. Pediatr Radiol 2003;33:99-103
6. Dubois J, Soulez G, Oliva VL, Berthiaume MJ, Lapierre C, Therasse E. Soft-tissue venous malformations in adult patients: imaging and therapeutic issues. Radiographics 2001;21:1519-31
7. Servelle M. Klippel and Trenaunay's syndrome. 768 operated cases. Ann Surg 1985;201:365-73
8. Gloviczki P, Stanson AW, Stickler GB, et al. Klippel-Trenaunay syndrome: the risks and benefits of vascular interventions. Surgery 1991;110:469-79
9. Paes EH, Vollmar JF. Aneurysma transformation in congenital venous angiodysplasias in lower extremities. Int Angiol 1990;9:90-6
10. Jacob AG, Driscoll DJ, Shaughnessy WJ, Stanson AW, Clay RP, Gloviczki P. Klippel-Trenaunay syndrome: spectrum and management. Mayo Clin Proc 1998;73:28-36
11. Drezner JA, O'Kane JW. Venous malformation of the palm in a collegiate crew athlete. J Am Board Fam Pract 2001;14:462-5
12. Malan E, Puglionisi A. Congenital angiodysplasias of the extremities. I. Generalities and classification; venous dysplasias. J Cardiovasc Surg 1964;5:87-130
13. Watson WL, McCarthy WD. Blood and lymph vessel tumors. Surg Gynecol Obstet 1940;71:569-88
14. Creton D. A nondraining saphenous system is a factor of poor prognosis for long-term results in surgery of great saphenous vein recurrences. Dermatol Surg 2004;30:744-9
15. El Wajeh Y, Giannoukas AD, Gulliford CJ, Suvarna SK, Chan P. Saphenofemoral venous channels associated with recurrent varicose veins are not neovascular. Eur J Vasc Endovasc Surg 2004;28:590-4
16. Creton D. Surgery for recurrent sapheno-femoral incompetence using expanded polytetrafluoroethylene patch interposition in front of the femoral vein: long-term outcome in 119 extremities. Phlebology 2002;16:137-141
17. Herborn CU, Goyen M, Lauenstein TC, Debatin JF, Ruehm SG, Kroger K. Comprehensive time-resolved MRI of peripheral vascular malformations. Am J Roentgenol 2003;181:729-35
18. Hyodoh H, Hori M, Akiba H, Tamakawa M, Hyodoh K, Hareyama M. Peripheral vascular malformations: imaging, treatment approaches, and therapeutic issues. Radiographics 2005;25:s159-71
19. Lookstein RA, Guller J. Embolization of complex vascular lesions. Mt Sinai J Med 2004;71:17-28
20. Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol 2004;15:431-45
21. Suh JS, Shin KH, Na JB, Won JY, Hahn SB. Venous malformations: sclerotherapy with a mixture of ethanol and lipiodol. Cardiovasc Interv Radiol 1997;20:268-73
22. Shireman PK, McCarthy WJ, Yao JS, Vogelzang RL. Treatment of venous malformations by direct injection with ethanol. J Vasc Surg 1997;26:838-844
23. Lee BB, Kim DI, Huh S, et al. New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation [comment]. J Vasc Surg 2001;33:764-72
24. Lee BB, Do YS, Byun HS, Choo IW, Kim DI, Huh SH. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg 2003;37:533-8
25. Mimura H, Kanazawa S, Yasui K, et al. Percutaneous sclerotherapy for venous malformations using polidocanol under fluoroscopy. Acta Med Okayama 2003;57:227-34
26. Yakes WF, Haas DK, Parker SH, et al. Symptomatic vascular malformations: ethanol embolotherapy. Radiology 1989;170:1059-66
27. Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 1999;104:1-11
28. Hammer FD, Boon LM, Mathurin P, Vanwijck RR. Ethanol sclerotherapy of venous malformations: evaluation of systemic ethanol contamination. J Vasc Interv Radiol 2001;12:595-600
29. Marrocco-Trischitta MM, Nicodemi EM, Nater C, Stillo F. Management of congenital venous malformations of the vulva. Obstet Gynecol 2001;98:789-93
30. Shin BS, Do YS, Lee BB, et al. Multistage ethanol sclerotherapy of soft-tissue arteriovenous malformations: effect on pulmonary arterial pressure. Radiology 2005;235:1072-7
31. Mason KP, Michna E, Zurakowski D, Koka BV, Burrows PE. Serum ethanol levels in children and adults after ethanol embolization or sclerotherapy for vascular anomalies. Radiology 2000;217:127-32
32. Garel L, Mareschal JL, Gagnadoux MF, Pariente D, Guilbert M, Sauvegrain J. Fatal outcome after ethanol renal ablation in child with end-stage kidneys. Am J Roentgenol 1986;146:593-4
33. Rimon U, Garniek A, Galili Y, Golan G, Bensaid P, Morag B. Ethanol sclerotherapy of peripheral venous malformations. Eur J Radiol 2004;52:283-7
34. O'Donovan JC, Donaldson JS, Morello FP, Pensler JM, Vogelzang RL, Bauer B. Symptomatic haemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate. Am J Roentgenol 1997;169:723-9
35. Lee JJ, Do YS, Kim JA. Serum ethanol levels after alcohol sclerotherapy of arteriovenous malformations. J Kor Med Sci 2004;19:51-4
36. Goyal M, Causer PA, Armstrong D. Venous vascular malformations in paediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification. Radiology 2002;223:639-44
37. Yakes WF, Luethke JM, Parker SH, et al. Ethanol embolization of vascular malformations. Radiographics 1990;10:787-96
38. Do YS, Yakes WF, Shin SW, et al. Ethanol embolization of arteriovenous malformations: interim results. Radiology 2005;235:674-82
39. Wysoki MG, White Jr RI. Crystallization when mixing contrast materials with ethanol for embolization of venous malformations. J Vasc Interv Radiol 2001;12:264
40. Dubois JM, Sebag GH, De Prost Y, Teillac D, Chretien B, Brunelle FO. Soft-tissue venous malformations in children: percutaneous sclerotherapy with Ethibloc. Radiology 1991;180:195-8
41. Niechajev I, Clodius L. Histologic investigation of vascular malformations of the face after transarterial embolization with Ethibloc and other agents. Plast Reconstr Surg 1990;86:664-71
42. Riche MC, Hadjean E, Tran-Ba-Huy P, Merland JJ. The treatment of capillary-venous malformations using a new fibrosing agent. Plast Reconstr Surg 1983;71:607-14
43. Ludwick J. Sclerosing agents: Baylor College of Medicine. [Taken from: http://www.bcm.edu/oto/grand/07-25-02.htm, 2002]
44. Dubois J, Garel L, Abela A, Laberge L, Yazbeck S. Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein. Radiology 1997;204:651-4
45. Rao J, Goldman MP. Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique. Dermatol Surg 2005;31:19-22
46. Kakkos SK, Bountouroglou DG, Azzam M, Kalodiki E, Daskalopoulos M, Geroulakos G. Effectiveness and safety of ultrasound-guided foam sclerotherapy for recurrent varicose veins: immediate results. J Endovasc Ther 2006;13:357-64
47. Cabrera J, Cabrera Jr J, Garcia-Olmedo MA, Redondo P. Treatment of venous malformations with sclerosant in microfoam form [see comment]. Arch Dermatol 2003;139:1409-16
48. Siniluoto TM, Svendsen PA, Wikholm GM, Fogdestam I, Edstrom S. Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (sotradecol). Scand J Plast Reconstr Surg Hand Surg 1997;31:145-50
49. Avram J. [Allergic shock after injection of sodium tetradecyl sulfate]. Phlebologie 1966;19:157-8
50. Marrocco-Trischitta MM, Nicodemi EM, Stillo F. Sclerotherapy for venous malformations of the glans penis. Urology 2001;57:310-13
51. Winter H, Drager E, Sterry W. Sclerotherapy for treatment of haemangiomas. Dermatol Surg 2000;26:105-8
52. Jain R, Bandhu S, Sawhney S, Mittal R. Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations. J Clin Ultrasound 2002;30:416-23
53. Marrocco-Trischitta MM, Guerrini P, Abeni D, Stillo F. Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation. Dermatol Surg 2002;28:153-5
54. Hyodoh H, Fujita A, Hyodoh K, Furuse M, Kamisawa O, Hareyama M. High-flow arteriovenous malformation of the lower extremity: ethanolamine oleate sclerotherapy. Cardiovasc Interv Radiol 2001;24:348-51
55. Connor WE, Hoak JC, Warner ED. Massive thrombosis produced by fatty acid infusion. J Clin Invest 1963;42:860-6
56. Choi YH, Han MH, Kwon O-K, Cha SH, Chang KH. Craniofacial cavernous venous malformations: percutaneous sclerotherapy with use of ethanolamine oleate. J Vasc Interv Radiol 2002;13:475-82
57. Miyoshi H, Ohshiba S, Matsumoto A, Takada K, Umegaki E, Hirata I. Haptoglobin prevents renal dysfunction associated with intravariceal infusion of ethanolamine oleate. Am J Gastroenterol 1991;86:1638-41
58. Hashizume M, Kitano S, Yamaga H, Sugimachi K. Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant. Lancet 1988;2:340-1
59. Yamaki T, Nozaki M, Sasaki K. Colour duplex-guided sclerotherapy for the treatment of venous malformations. Dermatol Surg 2000;26:323-8
60. Svendsen P, Wikholm G, Rodriguez-Catarino M. [Venous malformations in the head and neck should be treated]. Lakartidningen 2002;99:1574-8
61. Villavicencio JL. Primum non nocere: is it always true? The use of absolute ethanol in the management of congenital vascular malformations [see comment]. J Vasc Surg 2001;33:904-6
62. Froelich JJ, Ishaque N, Regn J, Saar B, Walthers EM, Klose KJ. Guidance of percutaneous pulmonary biopsies with real-time CT fluoroscopy. Eur J Radiol 2002;42:74-9
63. Schmid G, Schmitz A, Borchardt D, et al. Effective dose of CT- and fluoroscopy-guided perineural/epidural injections of the lumbar spine: a comparative study. Cardiovasc Interv Radiol 2006;29:84-91
64. Stoeckelhuber BM, Leibecke T, Schulz E, et al. Radiation dose to the radiologist's hand during continuous CT fluoroscopy-guided interventions. Cardiovasc Interv Radiol 2005;28:589-94
65. Carlson SK. Evaluation of patient and staff doses during various CT fluoroscopy guided interventions [comment]. Health Phys 2004;86:95-6
66. Boll DT, Merkle EM, Lewin JS. Low-flow vascular malformations: MR-guided percutaneous sclerotherapy in qualitative and quantitative assessment of therapy and outcome. Radiology 2004;233:376-84
67. Boll DT, Merkle EM, Lewin JS. MR-guided percutaneous sclerotherapy of low-flow vascular malformations in the head and neck. Magn Reson Imaging Clin N Am 2005;13:595-600
68. Gultali NZ, Kurt A, Ipek A, et al. The relation between pelvic varicose veins, chronic pelvic pain and lower extremity venous insufficiency in women. Diagn Interv Radiol 2006;12:34-8
69. Baskerville PA, Ackroyd JS, Lea Thomas M, Browse NL. The Klippel-Trenaunay syndrome: clinical, radiological and haemodynamic features and management. Br J Surg 1985;72:232-6
70. Sidhu MK, Perkins JA, Shaw DW, Bittles MA, Andrews RT. Ultrasound-guided endovenous diode laser in the treatment of congenital venous malformations: preliminary experience. J Vasc Interv Radiol 2005;16:879-884
71. van der Linden E, Overbosch J, Kroft LJ. Radiofrequency ablation for treatment of symptomatic low-flow vascular malformations after previous unsuccessful therapy. J Vasc Interv Radiol 2005;16:747-50